Trials / Recruiting
RecruitingNCT07230262
Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients (ACRO-IBD)
A Controlled Randomized Trial Comparing Multiport RObotic and Laparoscopic Surgery for Elective Colorectal Resections in IBD Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to better understand whether robotic surgery leads to better outcomes than laparoscopy in terms of complications, recovery and quality of life.
Detailed description
This clinical trial compares two surgical techniques, robotic surgery and conventional laparoscopic surgery, for patients with inflammatory bowel disease (IBD) requiring elective colorectal surgery. Both approaches are minimally invasive and commonly used in clinical practice. This is a randomized trial: participants will be randomly assigned to one of the two techniques. A total of 110 patients will be enrolled. This study will evaluate the role of robotic surgery in the surgical treatment of inflammatory bowel disease. Three quality-of-life questionnaires will be completed: before the procedure and at 30 and 90 days post-procedure. Pain will also be assessed during the first three days post-procedure using a specific score called the VAS. This study will be conducted exclusively at the University Hospitals Leuven.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Robotic colorectal surgery | Colorectal surgery using robotic procedure |
| PROCEDURE | Laparoscopic colorectal surgery | Colorectal surgery using laparoscopic procedure |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2028-05-01
- Completion
- 2028-12-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07230262. Inclusion in this directory is not an endorsement.